Chronic Inflammation and Exercise Responsiveness
Study Details
Study Description
Brief Summary
The purpose of this study is to determine how chronic inflammation influences skeletal muscle protein metabolism and metabolic function in humans. The investigators will evaluate acute responsiveness to a single bout of exercise in men and women who are either lean or overweight/obese. The investigators will explore the relationship between circulating inflammatory markers and anabolic, proteomic, and transcriptional responses to acute exercise. The investigators will measure skeletal muscle protein synthesis in the postabsorptive state and in response to a single bout of exercise.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Lean Body mass index less than 25 kg/m2 |
|
Overweight/obese Body mass index 25-45 kg/m2 |
Outcome Measures
Primary Outcome Measures
- Maximal oxygen consumption rates in mitochondria isolated from skeletal muscles [1 day]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Age 30-55 years
-
BMI 19-45 kg/m2
Exclusion Criteria:
-
Anemia (female subjects hemoglobin of <11 g/dl and male subjects hemoglobin <12 g/dl)
-
Active coronary artery disease or history of unstable macrovascular disease (unstable angina, myocardial infarction, stroke, and revascularization of coronary, peripheral or carotid artery within 3 months of recruitment)
-
Renal insufficiency/failure (serum creatinine > 1.5mg/dl)
-
Oral warfarin group medications or history of blood clotting disorders.
-
Pregnancy or breastfeeding
-
Alcohol consumption greater than 2 glasses/day or other substance abuse
-
Untreated or uncontrolled thyroid disorders
-
Debilitating chronic disease (at the discretion of the investigators)
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Mayo Clinic | Rochester | Minnesota | United States | 55905 |
Sponsors and Collaborators
- Mayo Clinic
Investigators
- Principal Investigator: Ian R Lanza, PhD, Mayo Clinic
Study Documents (Full-Text)
None provided.More Information
Additional Information:
Publications
None provided.- 16-000437